There has been a renewed interest using high dose vitamin C potentially administered intravenous, as there is evidence that large doses of vitamin C can kill cultured colon cancer cells with BRAF or KRAS mutations by raising free radical levels [45]. This evidence concerns the gene KRAS and malignant colon neoplasm.